Patent 7745646 was granted and assigned to KALYPSYS, INC. on June, 2010 by the United States Patent and Trademark Office.
The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.